🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Multiple-dose, steady state, three-way reference-replicated cross...
Status
Completed
Location
Woodland International Research Group, Inc.
Start Date
2013-07
Trial ID
NCT01948024
Bipolar disorder is characterized by mood swings that range from from high ...
Status
Completed
Location
Multiple Locations
Start Date
2005-07
Trial ID
NCT00159783
Treatments Being Tested
This is a 12-week study that will test the safety and efficacy of asenapine...
Status
Completed
Location
Multiple Locations
Start Date
2005-06-02
Trial ID
NCT00145470
Schizophrenia is a brain disease. The primary features of schizophrenia are...
Status
Completed
Location
Multiple Locations
Start Date
2005-04
Trial ID
NCT00156091
Treatments Being Tested
Schizophrenia is a brain disease. The primary features of schizophrenia are...
Status
Completed
Location
Multiple Locations
Start Date
2005-09
Trial ID
NCT00156065
Treatments Being Tested
The primary features of schizophrenia and schizoaffective disorder are posi...
Status
Completed
Location
Multiple Locations
Start Date
2004-09
Trial ID
NCT00212771
Treatments Being Tested
This is an open-label pilot study of adjunctive asenapine for the treatment...
Status
Completed
Location
Tuscaloosa VA Medical Center
Start Date
2012-06
Trial ID
NCT01587118
Treatments Being Tested
Treatment with conventional antipsychotics such as haloperidol has little e...
Status
Completed
Location
Multiple Locations
Start Date
2005-04-21
Trial ID
NCT00212836
Treatments Being Tested
The primary objective of this trial was to characterize the long-term (up t...
Status
Completed
Location
Multiple Locations
Start Date
2005-08
Trial ID
NCT00145509
This study evaluates the safety and tolerability of Asenapine in elderly pa...
Status
Completed
Location
Multiple Locations
Start Date
2006-02
Trial ID
NCT00281320
Treatments Being Tested